Christensen et al. 2013. Predicting transition temperature of elastin-like polypeptide fusion proteins. Biomacromolecules.
Christiansen et al. 2012. Weekly Subcutaneous Doses of (PB1023) a Novel GLP-1 Analogue Reduce Glucose Exposure Dose Dependently. Poster presentation at American Diabetes Association Annual Meeting 2012.
Kowalczyk et al. 2014. Elastin-like polypeptides as a promising family of genetically-engineered protein based polymers. World Journal of Microbiology and Biotechnology.
Luginbuhl et al. 2017. One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer. Nature Biomedical Engineering 1, Article number: 0078. doi:10.1038/s41551-017-0078.
Matson et al. 2011. (PB1023) a Novel GLP-1 Analogue Dose Dependently Reduces Meal Challenge Induced Glucose Exposure Following a Single Subcutaneous Dose. Poster presentation at the Annual Diabetes Technology Meeting 2011.
McDaniel et al. 2013. A unified model for de novo design of elastin-like polypeptides with tunable inverse transition temperatures. Biomacromolecules.